Default Category
-
Pirelli: Investing in Reifen Ritter
De Agostin, Luca; Liechtenstein, HeinrichCase F-793-EFinanceThe case describes the decision of the newly appointed Marketing and Sales Director in Germany for a tire producer regarding a loan request from an independent retailer. The case shows how suppliers can use credit lines and loans as instruments to "invest" in their clients, and the various potential benefits for the supplier in terms of growth (e.g. higher sales volumes, higher customer penetration, stronger customer loyalty, increased profitabil...Starting at €8.20
-
Pirelli: Invertir en Reifen Ritter
De Agostin, Luca; Liechtenstein, HeinrichCase F-793FinanceEste caso describe la decisión que debe tomar el nuevo director de marketing y ventas de un fabricante de neumáticos de Alemania con respecto a la solicitud de préstamo de un distribuidor independiente. A lo largo del caso se describe el uso que los proveedores hacen de las líneas de crédito y los préstamos, que utilizan como instrumentos para "invertir" en sus clientes, y los distintos beneficios que obtienen en términos de crecimiento (por ejem...Starting at €8.20
-
Dr. Reddy's Laboratories (B)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M065-EStrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Dr. Reddy's Laboratories (A)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M064-EStrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Dr. Reddy's Laboratories (A) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS64StrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Dr. Reddy's Laboratories (B) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS65StrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Schibsted (A): Should We Launch 20 Minutes
Jean-Louis Schaan; Jordan MitchellCase IVEY-9B07M019-EStrategyThe executive vice-president of newspapers for Schibsted was about to meet with his colleagues to discuss the company's plan to release an internally developed free daily newspaper concept called 20 Minutes. Over the past couple of years, Schibsted's executive team had kept a watchful eye on the free newspaper industry, which was enjoying tremendous popularity. Earlier in the year, Schibsted had launched Avis 1, a free paper with direct delivery ...Starting at €8.20